NCT05087420

Brief Summary

A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

May 4, 2022

Status Verified

May 1, 2022

Enrollment Period

8 months

First QC Date

September 19, 2021

Last Update Submit

May 3, 2022

Conditions

Keywords

migraineheadacherhinosinusitisCOVID-19

Outcome Measures

Primary Outcomes (2)

  • Headache phenotype

    Classification of reported headache according to International Classification of Headache Disorders

    in the preceding year

  • Migraine burden

    Consequences of the disease measured by the Migraine Disability Assessment Test

    in the preceding year

Secondary Outcomes (25)

  • Monthly headache days

    in the preceding month

  • Monthly headache days

    in the preceding year

  • Time from last headache professional consultation

    in the preceding 10 years

  • Migraine diagnosed by headache professional

    in the preceding 10 years

  • Age at diagnosis

    from the onset of headache (time frame up to 99 years)

  • +20 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participant will be recruited from miscellaneous sources including: specialist headache practices, primary care clinics, patients associations. An invitation would be also extended via social and traditional media and employers.

You may qualify if:

  • consent to participate in the study

You may not qualify if:

  • responses missing in questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Marcin Straburzyński

Dźwierzuty, Warmian-Masurian Voivodeship, 12-120, Poland

Location

Department of Neurology, Wrocław Medical University

Wroclaw, Poland

Location

Related Publications (1)

  • Straburzynski M, Waliszewska-Prosol M, Nowaczewska M, Czapinska-Ciepiela EK, Gryglas-Dworak A, Budrewicz S. Prevalence of cranial autonomic symptoms in frequent episodic tension-type headache: A post hoc analysis of the cross-sectional Migraine in Poland study. Dent Med Probl. 2024 Jul-Aug;61(4):489-493. doi: 10.17219/dmp/175611.

MeSH Terms

Conditions

Migraine DisordersHeadacheRhinosinusitisCOVID-19

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsRhinitisRespiratory Tract InfectionsInfectionsSinusitisParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPneumonia, ViralPneumoniaVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung Diseases

Study Officials

  • Marta Waliszewska-Prosół, MD, PhD

    Departament of Neurolog, Wrocław Medical University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General practitioner

Study Record Dates

First Submitted

September 19, 2021

First Posted

October 21, 2021

Study Start

September 1, 2021

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

May 4, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations